# Itraconazole Therapy In Bronchiectasis With Airway Mold

> **NCT07283497** · PHASE4 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 30 (estimated)

## Conditions studied

- Bronchiectasis
- Fungal Infection of Upper Respiratory Tract

## Interventions

- **DRUG:** Itraconazole 200 mg

## Key facts

- **NCT ID:** NCT07283497
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-15
- **Primary completion:** 2030-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07283497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07283497, "Itraconazole Therapy In Bronchiectasis With Airway Mold". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07283497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*